Author: Nicole Wetsman
Photo by Doug Mills/The New York Times/Pool/Getty Images
The Food and Drug Administration just authorized the emergency use of remdesivir, an experimental anti-viral drug, to treat COVID-19.
Emergency authorization does not mean that the drug is FDA-approved, a standard that only comes after a detailed review showing a drug can safely and effectively treat a particular disease. The agency can issue an emergency use authorization (EUA) for unapproved medical products that may help treat a life-threatening disease when no approved alternatives are available — that’s what it did here. The authorization does not mean the drug was proven to work.
Research showing that remdesivir blocks the activity of the novel coronavirus in cells made it a leading candidate to treat the disease. The drug was...
Continue reading…
Continue reading...
The Food and Drug Administration just authorized the emergency use of remdesivir, an experimental anti-viral drug, to treat COVID-19.
Emergency authorization does not mean that the drug is FDA-approved, a standard that only comes after a detailed review showing a drug can safely and effectively treat a particular disease. The agency can issue an emergency use authorization (EUA) for unapproved medical products that may help treat a life-threatening disease when no approved alternatives are available — that’s what it did here. The authorization does not mean the drug was proven to work.
Research showing that remdesivir blocks the activity of the novel coronavirus in cells made it a leading candidate to treat the disease. The drug was...
Continue reading…
Continue reading...